136 related articles for article (PubMed ID: 22673502)
1. Effect of metformin on hepatic glucose production in Japanese patients with type 2 diabetes mellitus.
Takahara M; Kaneto H; Katakami N; Matsuhisa M; Shimomura I
Endocr J; 2012; 59(9):845-7. PubMed ID: 22673502
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
[TBL] [Abstract][Full Text] [Related]
3. Mechanism by which metformin reduces glucose production in type 2 diabetes.
Hundal RS; Krssak M; Dufour S; Laurent D; Lebon V; Chandramouli V; Inzucchi SE; Schumann WC; Petersen KF; Landau BR; Shulman GI
Diabetes; 2000 Dec; 49(12):2063-9. PubMed ID: 11118008
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Effects of Metformin in Humans.
Adeva-Andany MM; Rañal-Muíño E; Fernández-Fernández C; Pazos-García C; Vila-Altesor M
Curr Diabetes Rev; 2019; 15(4):328-339. PubMed ID: 30306875
[TBL] [Abstract][Full Text] [Related]
5. Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes.
Iozzo P; Hallsten K; Oikonen V; Virtanen KA; Parkkola R; Kemppainen J; Solin O; Lonnqvist F; Ferrannini E; Knuuti J; Nuutila P
Diabetes Care; 2003 Jul; 26(7):2069-74. PubMed ID: 12832315
[TBL] [Abstract][Full Text] [Related]
6. The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms.
Wiernsperger NF; Bailey CJ
Drugs; 1999; 58 Suppl 1():31-9; discussion 75-82. PubMed ID: 10576523
[TBL] [Abstract][Full Text] [Related]
7. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.
Abbasi F; Kamath V; Rizvi AA; Carantoni M; Chen YD; Reaven GM
Diabetes Care; 1997 Dec; 20(12):1863-9. PubMed ID: 9405908
[TBL] [Abstract][Full Text] [Related]
8. Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
Triplitt C; Glass L; Miyazaki Y; Wajcberg E; Gastaldelli A; De Filippis E; Cersosimo E; DeFronzo RA
Diabetes Care; 2006 Nov; 29(11):2371-7. PubMed ID: 17065670
[TBL] [Abstract][Full Text] [Related]
9. Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.
Gastaldelli A; Nauck MA; Balena R
Metabolism; 2013 Sep; 62(9):1330-9. PubMed ID: 23831441
[TBL] [Abstract][Full Text] [Related]
10. Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes.
Hother-Nielsen O; Schmitz O; Andersen PH; Beck-Nielsen H; Pedersen O
Acta Endocrinol (Copenh); 1989 Mar; 120(3):257-65. PubMed ID: 2648723
[TBL] [Abstract][Full Text] [Related]
11. The effect of intravenous metformin on glucose metabolism during hyperglycaemia in type 2 diabetes.
Sum CF; Webster JM; Johnson AB; Catalano C; Cooper BG; Taylor R
Diabet Med; 1992; 9(1):61-5. PubMed ID: 1551312
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
DeFronzo RA; Barzilai N; Simonson DC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
[TBL] [Abstract][Full Text] [Related]
13. Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin.
Abbasi F; Carantoni M; Chen YD; Reaven GM
Diabetes Care; 1998 Aug; 21(8):1301-5. PubMed ID: 9702437
[TBL] [Abstract][Full Text] [Related]
14. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
An H; He L
J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
[TBL] [Abstract][Full Text] [Related]
15. Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review.
Natali A; Ferrannini E
Diabetologia; 2006 Mar; 49(3):434-41. PubMed ID: 16477438
[TBL] [Abstract][Full Text] [Related]
16. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.
Inzucchi SE; Maggs DG; Spollett GR; Page SL; Rife FS; Walton V; Shulman GI
N Engl J Med; 1998 Mar; 338(13):867-72. PubMed ID: 9516221
[TBL] [Abstract][Full Text] [Related]
18. Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.
Yoshida T; Okuno A; Tanaka J; Takahashi K; Nakashima R; Kanda S; Ogawa J; Hagisawa Y; Fujiwara T
Eur J Pharmacol; 2009 Nov; 623(1-3):141-7. PubMed ID: 19765581
[TBL] [Abstract][Full Text] [Related]
19. The role of metformin and thiazolidinediones in the regulation of hepatic glucose metabolism and its clinical impact.
Phielix E; Szendroedi J; Roden M
Trends Pharmacol Sci; 2011 Oct; 32(10):607-16. PubMed ID: 21824668
[TBL] [Abstract][Full Text] [Related]
20. The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients.
Johnson AB; Webster JM; Sum CF; Heseltine L; Argyraki M; Cooper BG; Taylor R
Metabolism; 1993 Sep; 42(9):1217-22. PubMed ID: 8412779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
